Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-27 Purchase | 2021-12-28 7:04 pm | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 7,000 | $0.59 | $4,130 | 7,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 7:55 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 475,600 | $0 | 475,600 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:12 pm | N/A 2033-07-10 | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:39 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 189,600 | $0 | 94,800 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:35 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 94,800 | $0 | 94,800 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:06 pm | N/A 2031-09-29 | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 100,000 | $0 | 100,000 (Direct) | View |